~~<i id='120D963E20'><strike id='120D963E20'><tt id='120D963E20'><pre id='120D963E20'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：comprehensive 2025-10-02 09:32:29 Page View：63

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Will biotech layoffs continue through 2023?
Next article： Peter Hotez and the public health issue of online harassment

explore

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

GoodSamaritanMedicalCenter,aMassachusettsHospital.SuzanneKreiter/GlobestaffStrugglingtobreathe,thepa

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Biden to sign 'historic' executive order on how US military handles sexual assault cases

2:12VIDEO:ArmyinvestigatingdeathofanotherFt.HoodsoldierwhocomplainedofsexualassaultBoZaunders/GettyI

WSS

hotspot

hotspot

focus

explore

Biden to sign 'historic' executive order on how US military handles sexual assault cases